Cronos Group Stock Today
| CRON Stock | CAD 3.55 0.03 0.85% |
PerformanceWeak
| Odds Of DistressFair
|
Cronos is selling at 3.55 as of the 14th of February 2026; that is 0.85 percent increase since the beginning of the trading day. The stock's open price was 3.52. Cronos has 47 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. The performance scores are derived for the period starting the 16th of November 2025 and ending today, the 14th of February 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada. The company has 382.89 M outstanding shares of which 3.25 M shares are currently shorted by private and institutional investors with about 16.61 days to cover all short positions. More on Cronos Group
Moving against Cronos Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Cronos Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cronos' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cronos or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Michael JD | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
Cronos' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Cronos' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsCronos utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Cronos' leverage profile, showing how much of Cronos' resources are funded through borrowing.
| |||||
Cronos Group (CRON) is traded on Toronto Exchange in Canada and employs 459 people. Cronos is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.36 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cronos's market, we take the total number of its shares issued and multiply it by Cronos's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cronos Group operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 382.89 M outstanding shares of which 3.25 M shares are currently shorted by private and institutional investors with about 16.61 days to cover all short positions.
Cronos Group has accumulated about 858.8 M in cash with 18.84 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.34.
Check Cronos Probability Of Bankruptcy
Ownership AllocationCronos holds a total of 382.89 Million outstanding shares. Cronos Group retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cronos Ownership Details
Cronos Historical Income Statement
Cronos Stock Against Markets
Cronos Stock Analysis Notes
About 47.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.92. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cronos Group had not issued any dividends in recent years. The entity had 1:7 split on the 17th of December 2014. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada. CRONOS GROUP operates under Drug ManufacturersSpecialty Generic classification in Canada and is traded on Toronto Stock Exchange. For more info on Cronos Group please contact Michael JD at 416 504 0004 or go to https://thecronosgroup.com.Cronos Group Investment Alerts
| Cronos Group had very high historical volatility over the last 90 days | |
| About 47.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Cronos sets Feb. 26 call to detail Q4 and full-year 2025 results - Stock Titan |
Cronos Largest EPS Surprises
Earnings surprises can significantly impact Cronos' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-05-10 | 2022-03-31 | -0.1 | -0.11 | -0.01 | 10 | ||
2020-05-08 | 2020-03-31 | -0.09 | -0.1 | -0.01 | 11 | ||
2018-08-14 | 2018-06-30 | -0.01 | -0.02 | -0.01 | 100 |
Cronos Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.36 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cronos's market, we take the total number of its shares issued and multiply it by Cronos's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Cronos Profitablity
Cronos' profitability indicators refer to fundamental financial ratios that showcase Cronos' ability to generate income relative to its revenue or operating costs. If, let's say, Cronos is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Cronos' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Cronos' profitability requires more research than a typical breakdown of Cronos' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.27 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.14. | Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.03 | 0.04 | |
| Return On Capital Employed | (0.06) | (0.06) | |
| Return On Assets | 0.03 | 0.03 | |
| Return On Equity | 0.03 | 0.04 |
Management Efficiency
Cronos Group has return on total asset (ROA) of (0.0139) % which means that it has lost $0.0139 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0367 %, meaning that it generated $0.0367 on every $100 dollars invested by stockholders. Cronos' management efficiency ratios could be used to measure how well Cronos manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Cronos' Return On Tangible Assets are very stable compared to the past year. As of the 14th of February 2026, Return On Assets is likely to grow to 0.03, while Return On Capital Employed is likely to drop (0.06). At this time, Cronos' Asset Turnover is very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.62 | 1.66 | |
| Tangible Book Value Per Share | 2.44 | 1.50 | |
| Enterprise Value Over EBITDA | (4.91) | (5.16) | |
| Price Book Value Ratio | 1.19 | 1.13 | |
| Enterprise Value Multiple | (4.91) | (5.16) | |
| Price Fair Value | 1.19 | 1.13 | |
| Enterprise Value | 222.9 M | 211.7 M |
Leadership effectiveness at Cronos Group is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 14th of February 2026, Cronos shows the Mean Deviation of 2.06, downside deviation of 2.53, and Risk Adjusted Performance of 0.0236. Cronos Group technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Cronos Group Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Cronos Group Tanh Of Price Series is a hyperbolic price transformation function.
Cronos Outstanding Bonds
Cronos issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cronos Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cronos bonds can be classified according to their maturity, which is the date when Cronos Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Cronos Predictive Daily Indicators
Cronos intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cronos stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 1838.95 | |||
| Daily Balance Of Power | 0.2727 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 3.56 | |||
| Day Typical Price | 3.55 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | 0.03 |
Cronos Forecast Models
Cronos' time-series forecasting models are one of many Cronos' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cronos' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
Our tools can tell you how much better you can do entering a position in Cronos without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Cronos Corporate Management
Elected by the shareholders, the Cronos' board of directors comprises two types of representatives: Cronos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cronos. The board's role is to monitor Cronos' management team and ensure that shareholders' interests are well served. Cronos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cronos' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lloyd Wilson | VP Officer | Profile | |
| Shayne Laidlaw | Director Strategy | Profile | |
| James Holm | Executive Officer | Profile | |
| Terry Doucet | General Secretary | Profile | |
| Kevin Gifford | VP Fin | Profile | |
| Anna Shlimak | Senior Strategy | Profile | |
| Carlos Cortez | Controller VP | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.